Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TargetEx is a Hungary-based biotechnology company specializing in drug discovery services and recombinant protein production. The company provides a comprehensive suite of services including molecular biology, protein expression in various systems, and the development of biochemical and cellular assays for high-throughput screening. Their protein expression capabilities span bacterial, insect, and mammalian cells, catering to complex target classes like GPCRs and ion channels. In addition to its CRO activities, TargetEx engages in internal research programs focused on ion channels and kinases for the treatment of inflammatory and autoimmune disorders. Their expertise bridges the gap between target identification and lead optimization for pharmaceutical and biotech partners. The company is recognized for its proficiency in electrophysiology and the development of specialized assays for ion channel drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TargetEx.